Work

Suramin is a novel competitive antagonist selective to α1β2γ2 GABAA over ρ1 GABAC receptors

Year: 2018

Type: article

Source: Neuropharmacology

DOI: 10.1016/j.neuropharm.2018.08.036

Authors: Hui Luo, Kristofer Wood, Fu-Dong Shi, Fenfei Gao, Yongchang Chang

Institutions: Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Shantou University, Shantou University Medical College

Language: English

Topic: Neuroscience and Neuropharmacology Research

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Barrow Neurological Foundation

OpenAlex ID: W2889429742

FWCI: 0.45

Cites: 59

Cited by: 8

Related to: 10